Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07693426
What this trial is testing

Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents

Who this might be right for
Adolescence Obesity
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 36
Not applicableStudy completedNCT07513259
What this trial is testing

Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

Who this might be right for
Obesity & OverweightDiabetes Mellitus Type 2Neoplasms
Chung Shan Medical University 203,424
Testing effectiveness (Phase 2)Study completedNCT05920889
What this trial is testing

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies

Who this might be right for
StrokeStroke, AcuteStroke, Ischemic+1 more
Chinese University of Hong Kong 140
Early research (Phase 1)Study completedNCT03350191
What this trial is testing

A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 13
Testing effectiveness (Phase 2)Looking for participantsNCT06903923
What this trial is testing

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Who this might be right for
Obesity in ChildrenBone StrengthGLP - 1+3 more
University of Virginia 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05254314
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Who this might be right for
Asthma
Vanderbilt University Medical Center 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07738276
What this trial is testing

Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity

Who this might be right for
Heart Failure and Reduced Ejection FractionObesity & OverweightTirzepatide
Shahid Beheshti University of Medical Sciences 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07179120
What this trial is testing

Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health

Who this might be right for
Obesity-related Male Infertility
First Affiliated Hospital of Wenzhou Medical University 180
Not applicableStudy completedNCT06608433
What this trial is testing

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Who this might be right for
Healthy Volunteer StudyHPACortisol Deficiency+1 more
University Hospital, Basel, Switzerland 22
Not applicableStudy completedNCT01767389
What this trial is testing

Glucagon-like Peptide (GLP) Utilization and Safety

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1
Large-scale testing (Phase 3)Study completedNCT05813795
What this trial is testing

Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

Who this might be right for
Weight Management
Hangzhou Sciwind Biosciences Co., Ltd. 664
Not applicableLooking for participantsNCT06686134
What this trial is testing

Comprehensive Clinical Evaluation Study of GLP-1RA

Who this might be right for
T2DM
LI YAN 492
Large-scale testing (Phase 3)Study completedNCT01794429
What this trial is testing

Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue

Who this might be right for
ObesityMetabolic Syndrome XDrug-induced Obesity+1 more
Bjorn H. Ebdrup 45
Not applicableStudy completedNCT07682857
What this trial is testing

Effects of an Arabinoxylan-enriched Rusk on Postprandial Glucose, Insulin, Glucagon-like Peptide-1 and Appetite Responses

Who this might be right for
Healthy Adult Participants
University of Turin, Italy 10
Not applicableLooking for participantsNCT07104539
What this trial is testing

Strength Training Response of Muscle in GLP-1 Users

Who this might be right for
Muscle Mass
Virginia Polytechnic Institute and State University 30
Testing effectiveness (Phase 2)Study completedNCT04199728
What this trial is testing

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Who this might be right for
Opiate Substitution TreatmentOpioid-Related Disorders
Milton S. Hershey Medical Center 27
Post-approval studies (Phase 4)Study completedNCT02602600
What this trial is testing

Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis

Who this might be right for
Microvascular Angina
Eva Prescott 33
Not applicableStudy completedNCT02746757
What this trial is testing

Glucagon Like Peptide-1 in Remote Ischemic Conditioning

Who this might be right for
Healthy Volunteers
Karolinska Institutet 12
Large-scale testing (Phase 3)Study completedNCT06739044
What this trial is testing

Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 494
Large-scale testing (Phase 3)Looking for participantsNCT07082114
What this trial is testing

Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 800
Next Page